引用本文:徐小琳.左旋卡尼汀对维持性血液透析患者生活质量和贫血的影响[J].中国临床新医学,2009,2(2):156-158.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1479次   下载 928 本文二维码信息
码上扫一扫!
分享到: 微信 更多
左旋卡尼汀对维持性血液透析患者生活质量和贫血的影响
徐小琳
514300,广东,丰顺县人民医院内一科
摘要:
[摘要] 目的 探讨左旋卡尼汀对维持性血透(MHD)患者生活质量和贫血的影响。方法 将30例维持性血透患者随机分为治疗组(15例)和对照组(15例)。两组透析结束后均使用重组人促红细胞生成素(rhEPO)3000IU皮下注射2~3次/周,而治疗组每次透析后加静脉注射左旋卡尼汀1 g。随访12周,分别在治疗前及治疗12周末给两组患者应用SF36系统进行生活质量评分并检测血红蛋白、红细胞压积、血浆白蛋白的情况。结果 治疗后治疗组患者的生活质量评分较治疗前有明显的上升,较对照组治疗后亦有明显的增高,差异均有统计学意义(P<0.01);治疗组的血红蛋白、血细胞比容、血浆白蛋白水平显著高于对照组,差异有统计学意义(P<0.01)。结论 静脉注射左旋卡尼汀可明显提高维持性血透患者生活质量和促进改善维持性血液透析患者的贫血。
关键词:  左旋卡尼汀  血液透析  生活质量  贫血
DOI:
分类号:R 692.5
基金项目:
Effects of L-carnitine on health-related quality of life and anemia in maintenance hemodialysis patients
XU Xiao-lin
Department of Internal Medicine, Fengshun County People′s Hospital, Guangdong 514300, China
Abstract:
[Abstract] Objective To investigate the effect of L-carnitine on quality of life and anemia in maintenance hemodialysis(MHD) patients. Methods  Thirty MHD patients were randomly divided into treatment group(n=15) and control group(n=15). All of the patients were received 3000IU of rhEPO subcutaneous injection, 2 to 3 times a week after hemodialysis.In treatment group, 1.0g of L-carnitine was infused to the patients at the end of each dialysis treatment for 12 weeks.SF36(Short Form with 36 questions)score about LQ were recorded and analyzed. Hb, Hct and Alb were measured before and after treatment.Results In treatment group each item was significantly increased after treatment (P<0.05) while no significant changes was found in control group.Conclusion Using L-carnitine may improve quality of life and anemia in MHD patients.
Key words:  L-carnitine  Hemodialysis  Quality of life  Anemia